Vaxxas announced that Merck exercised option to apply novel immune system activation platform for Vaccine candidate
On May 28, 2020, Vaxxas announced that Merck had exercised its option to utilize Vaxxas’ proprietary High Density…
-
-
Roche initiated phase III clinical trial of Actemra/RoActemra plus remdesivir in hospitalised patients with severe COVID-19 pneumonia
On May 28, 2020, Roche announced it had initiated of a global phase III, randomised, double-blind, multicentre study…
-
Novavax expanded large-scale global manufacturing capacity
On May 27, 2020, Novavax announced the acquisition of Praha Vaccines, part of the Cyrus Poonawalla Group, in…
-
IAVI and Merck announced collaboration to develop vaccine against SARS-CoV-2
On May 26, 2020, Merck and and IAVI, a nonprofit scientific research organization dedicated to addressing urgent, unmet…
-
Novavax initiated phase 1/2 clinical trial of COVID-19 vaccine
On May 26, 2020, Novavax announced enrollment of the first participants in a Phase 1/2 clinical trial of…
-
Biotechnology | COVID-19 | Disease | Infectious Disease | Measles | Polio | Therapeutics | Vaccine | WHO
At least 80 million children under one at risk of diseases such as diphtheria, measles and polio as COVID-19 disrupted routine vaccination efforts
On May 22, 2020, COVID 19 disrupted life-saving immunization services around the world, putting millions of children –…
-
Sinovac secured $15 million in funding to accelerate COVID-19 vaccine development
On May 22, 2020, Sinovac Biotech announced a transaction in which Advantech Capital and Vivo Capital have invested…
-
AstraZeneca advanced response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine
On May 21, 2020, AstraZeneca announced it was advancing its response to address the unprecedented challenges of COVID-19,…
-
Vaxart announced selection of its oral COVID-19 vaccine lead candidate
On May 20, 2020, Vaxart announced it has entered into an agreement with Vaxart for the manufacture of…
-
Rapid Micro Biosystems raised $120 million to accelerate global expansion of contaminant testing platform for pharmaceutical and vaccine manufacturing
On May 20, 2020, Rapid Micro Biosystems announced a $120 million financing round, led by equity investment from…
-
INOVIO COVID-19 DNA vaccine INO-4800 demonstrated robust neutralizing antibody and T cell immune responses in preclinical models
On May 20, 2020, INOVIO announced the publication of the preclinical study data for IN0-4800, its COVID-19 DNA…
-
Bharat Biotech and Thomas Jefferson University announced a promising vaccine candidate against COVID-19
On May 20, 2020, Bharat Biotech and Thomas Jefferson University of Philadelphia announced an exclusive deal to develop…
-
Oragenics and Aragen Bioscience enter agreement to accelerate development of TerraCoV2, a SARS-CoV-2 (COVID 19) vaccine candidate
On May 19, 2020, Oragenics announced, that through its wholly-owned subsidiary, Noachis Terra, it has entered into an…
-
Antibodies produced in response to one type of coronavirus don’t offer protection against the other, study suggests
On May 19, 2020, in a study published in Cell Reports, researchers at the University of Hong Kong…
-
Global study tested malaria drug to protect health workers from COVID-19
On May 18, 2020, with $9 million from the COVID-19 Therapeutics Accelerator, an international group of physicians and…
-
Biotechnology | COVID-19 | Infectious Disease | NIH | USDA | Vaccine
Investigational ChAdOx1 nCoV-19 vaccine protects monkeys against COVID-19 pneumonia
On May 16, 2020, a single dose of ChAdOx1 nCoV-19, an investigational vaccine against SARS-CoV-2, has protected six…
-
First detailed analysis of immune response to SARS-CoV-2 bodes well for COVID-19 vaccine development
On May 14, 2020, scientists at La Jolla Institute for Immunology (LJI) announced they had resolved the uncertainty…
-
University of Alberta researchers launched a joint effort with US-based Tonix Pharma to develop and test a vaccine against COVID-19
On May 13, 2020, University of Alberta (UA) researchers launched a joint effort with U.S.-based Tonix Pharmaceuticals to…
-
Biotechnology | Diagnostics | Infectious Disease | Influenza | Measles | Plague | Vaccine
BioMed X Institute launched rapid antiviral response platform to prevent future pandemics
On May 13, 2020, BioMed X, an independent research institute that identifies big biomedical research challenges and provides…
-
National Research Council of Canada and CanSino Biologics announced collaboration to advance vaccine against COVID-19
On May 12, 2020, the National Research Council of Canada (NRC) announced a collaboration with CanSino Biologics to…
-
National Research Council of Canada and USasks VIDO-InterVac collaborated to advance development of vaccine against COVID-19
On May 12, 2020, the National Research Council of Canada (NRC) and the University of Saskatchewan’s (USask) Vaccine…
-
U.S. Dept. of Veterans Affairs accepted mask donation from South Korea to assist with COVID-19 efforts
On May 12, 2020, the U.S. Dept. of Veterans Affairs (VA) announced it had accepted a donation of…
-
The Jackson Laboratory provided widescale COVID-19 testing in Connecticut
On May 12, 2020, the Jackson Laboratory (JAX), in partnership with the State of Connecticut, announced that it…
-
Moderna received FDA Fast Track Designation for mRNA vaccine (mRNA-1273) against novel Coronavirus
On May 12, 2020, Moderna announced the U.S. Food and Drug Administration (FDA had granted Fast Track designation…
-
Thermo Fisher Scientific to double its capacity of viral vector manufacturing
On May 11, 2020, Thermo Fisher Scientific announced it is expanding capacity for viral vector development and manufacturing…
-
Novavax received $388 million funding from CEPI for COVID-19 vaccine development and manufacturing
On May 11, 2020, Novavax announced that the Coalition for Epidemic Preparedness Innovations (CEPI) had committed to investing…
-
Fred Hutch, NIH experts outlined plan for COVID-19 vaccines
On May 11, 2020, in a perspective published by the journal Science, Dr. Larry Corey from the Fred…
-
Biotechnology | COVID-19 | FDA | Infectious Disease | NIH | Vaccine
NIH report coordinated strategy to accelerate multiple COVID-19 vaccine candidates is key
On May 11, 2020, a harmonized and collaborative approach to the clinical testing, scale-up and distribution of candidate…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Pharmaceutical | Therapeutics | Vaccine
USPTO announced COVID-19 Prioritized Examination Pilot Program for small and micro entities
On May 8, 2020, the U.S. Patent and Trademark Office (USPTO) announced a new COVID-19 Prioritized Examination Pilot…
-
Biotechnology | COVID-19 | Diagnostics | Environmental | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
Rice University COVID-19 research fund backed six new initiatives
On May 8, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it had funded…
